Utilizing the Patient Reported Outcomes Measurement Information System (PROMIS®) to increase referral to ancillary support services for severely symptomatic patients with gynecologic cancer

Research output: Contribution to journalArticle

Abstract

Objective: The Patient-Reported Outcomes Measurement Information System (PROMIS®) Network has developed a comprehensive repository of electronic patient reported outcomes measures (ePROs) of major symptom domains that have been validated in cancer patients. Their use for patients with gynecologic cancer has been understudied. Our objective was to establish feasibility and acceptability of PROMIS ePRO integration in a gynecologic oncology outpatient clinic and assess if it can help identify severely symptomatic patients and increase referral to supportive services. Methods: English-speaking patients with a confirmed history of gynecologic cancer completed PROMIS ePROs on iPads in the waiting area of an outpatient gynecologic oncology clinic. Symptom scores were calculated for each respondent and grouped using documented severity thresholds. Response data was compared with clinicopathologic characteristics across symptom domains. Severely symptomatic patients were offered referral to ancillary services and asked to complete post-exposure surveys assessing acceptability of the ePRO. Results: Of the 336 patients who completed ePROs, 35% had active disease and 19% had experienced at least one disease recurrence. Sixty-nine percent of the cohort demonstrated moderate to severe physical dysfunction (60%), pain (36%), fatigue (28%), anxiety (9%), depression (8%), and sexual dysfunction (32%). Thirty-nine (12%) severely symptomatic patients were referred to services such as psychiatry, palliative care, pain management, social work or integrative oncology care. Most survey respondents identified the ePROs as helpful (78%) and easy to complete (92%). Conclusions: Outpatient PROMIS ePRO administration is feasible and acceptable to gynecologic oncology patients and can help identify severely symptomatic patients for referral to ancillary support services.

Original languageEnglish (US)
JournalGynecologic Oncology
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Information Systems
Referral and Consultation
Neoplasms
Patient Reported Outcome Measures
Outpatients
Information Services
Pain Management
Ambulatory Care Facilities
Social Work
Palliative Care
Fatigue
Psychiatry
Anxiety
Depression
Recurrence
Pain
Surveys and Questionnaires

Keywords

  • Cancer symptoms
  • Computer adaptive test
  • ePRO
  • Health related quality of life
  • Patient reported outcomes
  • PROMIS

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this

@article{e6b823999e5b4102ad38e81a51c4ec3e,
title = "Utilizing the Patient Reported Outcomes Measurement Information System (PROMIS{\circledR}) to increase referral to ancillary support services for severely symptomatic patients with gynecologic cancer",
abstract = "Objective: The Patient-Reported Outcomes Measurement Information System (PROMIS{\circledR}) Network has developed a comprehensive repository of electronic patient reported outcomes measures (ePROs) of major symptom domains that have been validated in cancer patients. Their use for patients with gynecologic cancer has been understudied. Our objective was to establish feasibility and acceptability of PROMIS ePRO integration in a gynecologic oncology outpatient clinic and assess if it can help identify severely symptomatic patients and increase referral to supportive services. Methods: English-speaking patients with a confirmed history of gynecologic cancer completed PROMIS ePROs on iPads in the waiting area of an outpatient gynecologic oncology clinic. Symptom scores were calculated for each respondent and grouped using documented severity thresholds. Response data was compared with clinicopathologic characteristics across symptom domains. Severely symptomatic patients were offered referral to ancillary services and asked to complete post-exposure surveys assessing acceptability of the ePRO. Results: Of the 336 patients who completed ePROs, 35{\%} had active disease and 19{\%} had experienced at least one disease recurrence. Sixty-nine percent of the cohort demonstrated moderate to severe physical dysfunction (60{\%}), pain (36{\%}), fatigue (28{\%}), anxiety (9{\%}), depression (8{\%}), and sexual dysfunction (32{\%}). Thirty-nine (12{\%}) severely symptomatic patients were referred to services such as psychiatry, palliative care, pain management, social work or integrative oncology care. Most survey respondents identified the ePROs as helpful (78{\%}) and easy to complete (92{\%}). Conclusions: Outpatient PROMIS ePRO administration is feasible and acceptable to gynecologic oncology patients and can help identify severely symptomatic patients for referral to ancillary support services.",
keywords = "Cancer symptoms, Computer adaptive test, ePRO, Health related quality of life, Patient reported outcomes, PROMIS",
author = "Gressel, {Gregory M.} and Dioun, {Shayan M.} and Michael Richley and Lounsbury, {David W.} and Rapkin, {Bruce D.} and Isani, {Sara S.} and Nevadunsky, {Nicole S.} and Kuo, {Dennis Yi-Shin} and Novetsky, {Akiva P.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.ygyno.2018.10.042",
language = "English (US)",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Utilizing the Patient Reported Outcomes Measurement Information System (PROMIS®) to increase referral to ancillary support services for severely symptomatic patients with gynecologic cancer

AU - Gressel, Gregory M.

AU - Dioun, Shayan M.

AU - Richley, Michael

AU - Lounsbury, David W.

AU - Rapkin, Bruce D.

AU - Isani, Sara S.

AU - Nevadunsky, Nicole S.

AU - Kuo, Dennis Yi-Shin

AU - Novetsky, Akiva P.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objective: The Patient-Reported Outcomes Measurement Information System (PROMIS®) Network has developed a comprehensive repository of electronic patient reported outcomes measures (ePROs) of major symptom domains that have been validated in cancer patients. Their use for patients with gynecologic cancer has been understudied. Our objective was to establish feasibility and acceptability of PROMIS ePRO integration in a gynecologic oncology outpatient clinic and assess if it can help identify severely symptomatic patients and increase referral to supportive services. Methods: English-speaking patients with a confirmed history of gynecologic cancer completed PROMIS ePROs on iPads in the waiting area of an outpatient gynecologic oncology clinic. Symptom scores were calculated for each respondent and grouped using documented severity thresholds. Response data was compared with clinicopathologic characteristics across symptom domains. Severely symptomatic patients were offered referral to ancillary services and asked to complete post-exposure surveys assessing acceptability of the ePRO. Results: Of the 336 patients who completed ePROs, 35% had active disease and 19% had experienced at least one disease recurrence. Sixty-nine percent of the cohort demonstrated moderate to severe physical dysfunction (60%), pain (36%), fatigue (28%), anxiety (9%), depression (8%), and sexual dysfunction (32%). Thirty-nine (12%) severely symptomatic patients were referred to services such as psychiatry, palliative care, pain management, social work or integrative oncology care. Most survey respondents identified the ePROs as helpful (78%) and easy to complete (92%). Conclusions: Outpatient PROMIS ePRO administration is feasible and acceptable to gynecologic oncology patients and can help identify severely symptomatic patients for referral to ancillary support services.

AB - Objective: The Patient-Reported Outcomes Measurement Information System (PROMIS®) Network has developed a comprehensive repository of electronic patient reported outcomes measures (ePROs) of major symptom domains that have been validated in cancer patients. Their use for patients with gynecologic cancer has been understudied. Our objective was to establish feasibility and acceptability of PROMIS ePRO integration in a gynecologic oncology outpatient clinic and assess if it can help identify severely symptomatic patients and increase referral to supportive services. Methods: English-speaking patients with a confirmed history of gynecologic cancer completed PROMIS ePROs on iPads in the waiting area of an outpatient gynecologic oncology clinic. Symptom scores were calculated for each respondent and grouped using documented severity thresholds. Response data was compared with clinicopathologic characteristics across symptom domains. Severely symptomatic patients were offered referral to ancillary services and asked to complete post-exposure surveys assessing acceptability of the ePRO. Results: Of the 336 patients who completed ePROs, 35% had active disease and 19% had experienced at least one disease recurrence. Sixty-nine percent of the cohort demonstrated moderate to severe physical dysfunction (60%), pain (36%), fatigue (28%), anxiety (9%), depression (8%), and sexual dysfunction (32%). Thirty-nine (12%) severely symptomatic patients were referred to services such as psychiatry, palliative care, pain management, social work or integrative oncology care. Most survey respondents identified the ePROs as helpful (78%) and easy to complete (92%). Conclusions: Outpatient PROMIS ePRO administration is feasible and acceptable to gynecologic oncology patients and can help identify severely symptomatic patients for referral to ancillary support services.

KW - Cancer symptoms

KW - Computer adaptive test

KW - ePRO

KW - Health related quality of life

KW - Patient reported outcomes

KW - PROMIS

UR - http://www.scopus.com/inward/record.url?scp=85055972556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055972556&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2018.10.042

DO - 10.1016/j.ygyno.2018.10.042

M3 - Article

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

ER -